{"transactions":[{"id":826567,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":55653,"kind":"person","name":"Reznick Yehuda","position":1,"cik":"0002015556","reported_name":"Reznick Yehuda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, no par value per share","published_at":"2026-03-27T16:56:03.000Z","date":"2026-03-25","kind":"grant","planned":false,"acquired":true,"shares":7657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units (\"RSUs\") granted on March 25, 2026 (the \"Grant Date\") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date."}],"balance_after":7657,"source":{"system":"sec-edgar","filing":"0001178913-26-001816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015556/000117891326001816/ownership.xml","form_type":"4"}},{"id":952503,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":55653,"kind":"person","name":"Reznick Yehuda","position":1,"cik":"0002015556","reported_name":"Reznick Yehuda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T22:21:36.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer."}],"balance_after":105180,"source":{"system":"sec-edgar","filing":"0001213900-26-001282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026001282/ownership.xml","form_type":"4"}},{"id":952502,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":55653,"kind":"person","name":"Reznick Yehuda","position":1,"cik":"0002015556","reported_name":"Reznick Yehuda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T22:21:36.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share (\"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share (\"Common Stock\"), of the Issuer."}],"balance_after":98930,"source":{"system":"sec-edgar","filing":"0001213900-26-001282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390026001282/ownership.xml","form_type":"4"}},{"id":1118365,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":55653,"kind":"person","name":"Reznick Yehuda","position":1,"cik":"0002015556","reported_name":"Reznick Yehuda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:08:06.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":8370,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":68930,"source":{"system":"sec-edgar","filing":"0001213900-25-052622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025052622/ownership.xml","form_type":"4"}},{"id":1118364,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":55653,"kind":"person","name":"Reznick Yehuda","position":1,"cik":"0002015556","reported_name":"Reznick Yehuda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:08:06.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":60560,"source":{"system":"sec-edgar","filing":"0001213900-25-052622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025052622/ownership.xml","form_type":"4"}},{"id":1485307,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":55653,"kind":"person","name":"Reznick Yehuda","position":1,"cik":"0002015556","reported_name":"Reznick Yehuda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T21:15:29.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":760,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of 760 Restricted Stock Units (\"RSUs\") that will vest in two equal installments on October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":30560,"source":{"system":"sec-edgar","filing":"0001213900-24-051336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024051336/ownership.xml","form_type":"4"}},{"id":1539345,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":55653,"kind":"person","name":"Reznick Yehuda","position":1,"cik":"0002015556","reported_name":"Reznick Yehuda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-19T00:07:41.000Z","date":"2024-04-17","kind":"grant","planned":false,"acquired":true,"shares":29800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents (i) a grant of 22,500 Restricted Stock Units (\"RSUs\") that will vest in equal installments on January 1, 2025, January 1, 2026 and January 1, 2027 and (ii) grants of 5,070 and 2,230 RSUs that will each vest in nearly equal installments on July 1, 2024, October 1, 2024 and January 1, 2025. In each case, the RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":29800,"source":{"system":"sec-edgar","filing":"0001213900-24-034222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024034222/ownership.xml","form_type":"4"}}]}